Silvia Ling

Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1

Silvia Ling, Edwin Lau, Ammira Al-Shabeeb et al. · Haematologica · 2011 · 127 citations · Full text

Bisphosphonate guidelines for treatment and prevention of myeloma bone disease

Oi Lin Lee, Noemi Horvath, Cindy Lee et al. · Internal Medicine Journal · 2017 · 28 citations · Full text

Bone Disease, Translational Medicine, Adverse Events +14

The prognostic value of mid- and post-treatment [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in indolent follicular lymphoma

Lu Zhou, Michael Lin, Paul Downe et al. · Annals of Nuclear Medicine · 2014 · 27 citations

Positron Emission Tomography, Indolent Follicular Lymphoma, Lymphoid Neoplasia +5

Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation?

Silvia Ling, Douglas Joshua, John Gibson et al. · American Journal of Hematology · 2006 · 18 citations

Purine Analogue, Lymphoid Neoplasia, Translational Medicine +15

The Role of Chaperone-Mediated Autophagy in Bortezomib Resistant Multiple Myeloma

Nicholas Nikesitch, Patricia Rebeiro, Lye Lin Ho et al. · Cells · 2021 · 17 citations · Full text